| # | Drug | Count |
|---|---|---|
| 0 | MYCOPHENOLATE MOFETIL | 59 |
| 1 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 59 |
| 2 | TACROLIMUS | 54 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 52 |
| 4 | TACROLIMUS OINTMENT 0.1% | 52 |
| 5 | METHYLPREDNISOLONE | 45 |
| 6 | RITUXIMAB | 25 |
| 7 | PREDNISONE | 22 |
| 8 | CYCLOPHOSPHAMIDE | 17 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TREOSULFAN | 14 | 0.0051 |
| 1 | ACONITUM NAPELLUS, ARSENIC TRIOXIDE, ATROPA BELLADONNA, BRYONIA ALBA ROOT, EUPATORIUM PERFOLIATUM FLOWERING TOP, FERRUM PHOSPHORICUM, GELSEMIUM SEMPERVIRENS ROOT | 1 | 0.0024 |
| 2 | TOFERSEN | 1 | 0.0018 |
| 3 | THIOTEPA | 14 | 0.0014 |
| 4 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 7 | 0.0009 |
| 5 | BASILIXIMAB | 9 | 0.0008 |
| 6 | FOSCARNET SODIUM | 3 | 0.0007 |
| 7 | CIDOFOVIR ANHYDROUS | 1 | 0.0007 |
| 8 | EDARAVONE | 1 | 0.0006 |
| 9 | VALGANCICLOVIR | 10 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 13 | 0.0006 |
| 1 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 2 | Benzothiazole [EPC] | 1 | 0.0004 |
| 3 | Lipid-based Polyene Antifungal [EPC] | 5 | 0.0004 |
| 4 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 5 | Human alpha-1 Proteinase Inhibitor [EPC] | 1 | 0.0002 |
| 6 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 7 | Selective T Cell Costimulation Blocker [EPC] | 1 | 0.0002 |
| 8 | Non-Standardized Insect Allergenic Extract [EPC] | 1 | 0.0002 |
| 9 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |